Literature DB >> 23599215

Perioperative fluid management and use of vasoactive and antithrombotic agents in free flap surgery: a literature review and clinical recommendations.

J Nick Brinkman1, Lieke H Derks, Markus Klimek, Marc A M Mureau.   

Abstract

LEARNING
OBJECTIVES: After reading this article, the participant should be able to (1) outline the rationale for different perioperative types of fluid therapy in free flap surgery and identify the methods considered best for flap survival; (2) understand the current views on the use of vasoactive agents and consider its possible safe use; (3) compare the most commonly used intraoperative and postoperative anticoagulant therapies and identify the risks and benefits associated with each.
BACKGROUND: Free flap surgery has become a reliable and efficient method for reconstruction of complex soft tissue and bony defects. Despite high success rates, free flap failure remains an important concern. A review of the literature was conducted on nonsurgical factors that may contribute to flap failure or success. Various anesthesiological and anticoagulant methods are applied in free flap surgery, but for the ideal approach there is no consensus. This article provides clinical recommendations on perioperative fluid management and the use of vasoactive and antithrombotic agents and offers a balanced view on the risks and benefits. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23599215     DOI: 10.1055/s-0033-1343955

Source DB:  PubMed          Journal:  J Reconstr Microsurg        ISSN: 0743-684X            Impact factor:   2.873


  8 in total

Review 1.  Perioperative Care of Free Flap Patients.

Authors:  Aurora Vincent; Raja Sawhney; Yadranko Ducic
Journal:  Semin Plast Surg       Date:  2019-03-08       Impact factor: 2.314

2.  The use of tranexamic acid in microsurgery-is it safe?

Authors:  Alessia M Lardi; Kathrin Dreier; Klaus Junge; Jian Farhadi
Journal:  Gland Surg       Date:  2018-08

3.  Goal-directed fluid therapy in autologous breast reconstruction results in less fluid and more vasopressor administration without outcome compromise.

Authors:  Thais O Polanco; Meghana G Shamsunder; Madeleine E V Hicks; Kenneth P Seier; Kay See Tan; Sabine Oskar; Joseph H Dayan; Joseph J Disa; Babak J Mehrara; Robert J Allen; Jonas A Nelson; Anoushka M Afonso
Journal:  J Plast Reconstr Aesthet Surg       Date:  2021-02-04       Impact factor: 3.022

4.  Liberal versus Modified Intraoperative Fluid Management in Abdominal-flap Breast Reconstructions. A Clinical Study.

Authors:  Thomas Sjöberg; Anmar Numan; Louis de Weerd
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-09-17

5.  Serial Perioperative Assessment of Free Flap Perfusion With Laser Angiography.

Authors:  Anthony Massaro; Juliana Gomez; Ashleigh Michelle Weyh; Anthony Bunnell; Matthew Warrick; Philip Pirgousis; Rui Fernandes
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2020-06-15

Review 6.  Anticoagulants and Statins As Pharmacological Agents in Free Flap Surgery: Current Rationale.

Authors:  Adnan Pršić; Elizabeth Kiwanuka; Stephanie A Caterson; Edward J Caterson
Journal:  Eplasty       Date:  2015-11-20

7.  Impact of Goal Directed Therapy in Head and Neck Oncological Surgery with Microsurgical Reconstruction: Free Flap Viability and Complications.

Authors:  Blanca Tapia; Elena Garrido; Jose Luis Cebrian; Jose Luis Del Castillo; Javier Gonzalez; Itsaso Losantos; Fernando Gilsanz
Journal:  Cancers (Basel)       Date:  2021-03-27       Impact factor: 6.639

8.  Perioperative predictors of early surgical revision and flap-related complications after microvascular free tissue transfer in head and neck reconstructions: a retrospective observational series.

Authors:  John-Patrik Burkhard; Jelena Pfister; Roland Giger; Markus Huber; Claudia Lädrach; Manuel Waser; Radu Olariu; Dominique Engel; Lukas M Löffel; Benoît Schaller; Patrick Y Wuethrich
Journal:  Clin Oral Investig       Date:  2021-03-08       Impact factor: 3.573

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.